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ABSTRACT 
EXPRESSION DOMAIN OF ALK2 BMP RECEPTOR IN 
CHICK EMBRYOS BY IN SITU HYBRIDIZATION 
by Maryam Shenasa 
Statistics show that congenital heart disorder occurs in approximately 1% of live 
infants, leading to early mortality. Studies have shown that Bone Morphogenetic Proteins 
(BMPs) are highly involved in cardiogenesis. BMPs are part of the TGFp super-family and 
their cellular activities includes binding to heterodimeric receptors that through their 
intrinsic serine threonine kinase activity phosphorylate and activate downstream SMADs, 
which in turn carry out gene transcription. Alk2 is one of the essential type I receptors that 
has been reported to be involved in epithelial-to-mesenchymal transformation and heart 
looping. 
We have cloned, sequenced, and analyzed chick Alk2 mRNA. Additionally, we 
examined its spatial expression pattern in the heart using in situ hybridization during H&H 
stage 18 and found it present in the outflow tract, atrium and ventricles. 
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1. INTRODUCTION 
1.1. Heart Development and Morphology Changes 
The heart undergoes an extremely complicated process of morphogenesis transiting 
through five stages of development in order to reach the final shape of a four-chambered 
heart. During these stages of development, there are numerous signaling errors that could 
occur, leading to congenital heart defects potentially causing serious blood flow or heart 
rhythm abnormalities. Statistical studies estimate that 0.5% to 1% of live newborns are 
born with this defect and place congenital heart disease as the leading cause of death from 
birth defects (Delot 27; Armstrong and Bischoff 459). Recently, an article in the Journal of 
the American Heart Association stated that: 
Cardiovascular malformations are the most common congenital anomaly, 
occurring in four to six infants for every 1000 live births.. .In adults, 
valvular heart disease remains a major cause of morbidity and mortality; 
approximately 82,000 valve replacements are performed each year in the 
USA.. .An increased molecular understanding of the processes controlling 
heart valve development and remodeling will continue to suggest new 
therapeutic modalities. (Armstrong and Bischoff 459) 
Understanding pathways involved in heart differentiation and formation will help our 
understanding of this significant problem. 
The heart is the first organ to differentiate and function. During the early gastrula 
stage, cardiogenic tissue development is directed by molecular signals acting on the 
precardiac mesoderm as it migrates into the heart-forming region (Nakajima et al. 119-27). 
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In chick embryos, this occurs around Hamburger & Hamilton (HH) stage 3.1 Afterwards, 
left and right precardiac mesoderm form the pleura-pericardial cavity at stage 5 of 
development. During embryonic folding, the heart-forming regions migrate to the ventral 
midline of the body and fuse with each other to form the myocardial mantle, which is a 
straight symmetrical tube called the primitive heart tube. This folding and fusion occurs 
between HH stages 7 and 9 (Schlange et al. 259-70). At HH stage 10, the primitive heart 
tube spontaneously starts to beat (D. Wang et al. al-15). Subsequently, the heart tube 
generates a right-sided bend (d-loop), and other cardiac segments such as the primitive 
right and left ventricles, outflow tract (OT), atrio-ventricular canal (AVC), atrium, and 
sinus venous begin to emerge. After completion of the d-loop, the extracellular matrix 
(cardiac jelly) between the myocardium and endocardium layers of the AVC and OT 
converts to mesenchymal cells, which migrate into adjacent cardiac jelly to form 
endocardial cushion tissue (Nakajima et al. 119-27). This is called the epithelial-to-
mesenchymal transformation (EMT) which usually occurs in chick development at HH 
stage 16-17 (Delot 27-35). The heart valve and septa derived from cardiac cushions divide 
the heart into four functional chambers (Chang, Brown, and Matzuk 787-823). 
All embryos in this thesis are staged according to Hamburger and Hamilton (1951). 
The figure below (Nakajima et al. 120) illustrates pictorially the changes that occur 
initially in the precardiac mesoderm, and later to the heart tube to form the four-chambered 
heart. 
Cardiac 
morphogenesis 
Pr»C»r*«C 
nwodfm 
PrlmitN» heart tub* 
UMping 
NturaJ craat cMs 
Cushion ttttu* 
TrabtcuWcn 
mwvtntncuHr ttphm' 
Stputkw 
FftUKftmbOTd 
Figure 1. Illustration of Heart Differentiation: This figure was reprinted with permission 
of Wiley-Liss, Inc. a subsidiary of John Wiley & Sons, Inc. 1. Precardiac mesoderm 
specification. 2. During embryonic folding, the heart-forming regions migrate to the 
ventral midline of the body and fuse with each other to form the myocardial mantle, which 
is a straight symmetrical tube called the primitive heart tube. 3. The heart tube generates a 
right-sided bend (d-loop), and other cardiac segments begin to emerge. 4, 5. Epithelial-to-
mesenchymal transformation of the cardiac jelly occurs and the heart valve and septa 
derived from cardiac cushions divide the heart into four functional chambers. 
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Numerous studies have shown that Bone Morphogenetic Proteins play an important 
role in heart formation and development (Delot 27-35; hiai et al. 383-96; Miyazono et al. 
251-63; Nakajima et al. 119-27; Schlange et al. 259-70). 
Mice with mutations in BMP pathways exhibit severe heart developmental defects; 
many so profound, that the fetus succumbs to early gestational lethality (Dudley and 
Robertson 349-62; Roelen et al. 541-9; Gaussin et al. 2878-83). 
Experiments culruring heart tissue from regions of the developing heart in a collagen 
gel containing media, provide strong supporting evidence that elimination of specific 
BMPs at a given stage could potentially inhibit the tissue from further differentiation. 
Finally, in situ hybridization experiments have started to clarify the location and timing of 
BMP expression in the developing heart. The importance of BMPs and their receptors in 
heart formation and differentiation is well documented. 
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1.2. Bone Morphogenetic Proteins 
Bone Morphogenetic Proteins (BMPs) are members of the Transforming Growth 
Factor beta (TGF|3) gene family and play multiple roles in the developing embryo 
including morphogenesis and pattern formation. TGFp super-family ligands initiate 
signaling through heterodimeric receptors which are transmembrane serine/threonine 
kinases. Based on their structure and functional properties, these receptors are divided into 
two subgroups: type I and type II receptors (Chang, Brown, and Matzuk 787-823). When a 
ligand binds to a type II receptor, it recruits and transphosphorylates the type I receptor. 
This activates the type I receptor and allows it to associate with receptor-regulated SMAD2 
proteins, and phosphorylate them. Once these R-SMADs3 are phosphorylated, they 
associate with a common partner, SMAD4, and translocate to the nucleus (Macias-Silva et 
al. 25628-36). In the nucleus the R-SMAD/co-SMAD complex can initiate transcription of 
target genes. TGFp molecules regulate processes as diverse as tumor progression, wound 
healing, and embryonic development in vertebrates (Grazul-Bilska et al. 787-800; 
Desgrosellier et al. 201-10; Waite and Eng 763-73). The super-family consists of more 
than 35 members, including TGFps, BMPs, GDFs,4 activins, inhibins, MIS,5 Nodal, and 
leftys. Figure 2 shows a family tree of the TGFp super-family by using a PILEUP program 
Small Mothers Against Decapentaplegic are a class of proteins that modulate the activity of TGF beta * 
ligands. 
Receptor associated SMADs are also referred to as R-SMADs. 
Growth Differentiation Factors 
MDllerian Inhibiting Substance 
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from the Genetics Computer Group in Madison, Wisconsin (Chang, Brown, and Matzuk 
788). 
d 
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Figure 2. Different Subgroups of TGF|3 Super-family: This figure was reprinted with 
permission of The Endocrine Society (Copyright 2002, The Endocrine Society). It is 
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important to note the relation different subgroups of BMPs have in the family tree above as 
we will later see that BMPs are also categorized according to their structure and 
functionality. The image above was compiled using amino acid sequence alignment 
programs such as PILEUP from the Genetics Computer Group in Madison, Wisconsin. . 
Based on their amino acid structure and functionality, the BMPs can be categorized 
into as many as 20 subgroups. BMP-2 and BMP-4 have their own category, BMPs -5, -6, 
and -7 are in another category, and BMPs -8A and -8B are the third important subgroup 
(Miyazono et al. 251-63). These subgroups have close amino acid sequences (Fig. 2). 
Within each subgroup, individual members have approximately 90% amino acid identity, 
while different subgroups have only 60% identity (Dudley and Robertson 349-62). This 
categorization is important when interpreting spatiotemporal expression levels of BMPs in 
the chick heart, and which BMP ligands may share type I receptors. 
BMP receptors are divided into two classes based on their amino acid structure and 
function: type I and type II receptors. Type I and type II receptors are glycoproteins of 
approximately 55 kDa and 70 kDa, respectively. These receptors have about 150 amino 
acids in their extracellular region. Type I receptors have a highly conserved 30 amino acid 
stretch that is Gly-Ser rich due to its SGSGSG sequence. This portion is known as its GS 
domain, located intracellularly, and gets phosphorylated by type II receptors during ligand-
induced signal transduction (Chang, Brown, and Matzuk 787-823). Due to the activation 
of signal through the phosphorylation of type I receptors, the specificity of the intracellular 
signal is mainly determined by these receptors. There are three type I receptors to which 
BMPs bind: Alk2, Alk3, and Alk66 also known as ActRIIA, BMPR-IA, and BMPR-IB 
respectively. Alk3 and Alk6 are structurally more similar to each other; whereas Alk2 is 
less similar. BMP-2 and BMP-4 preferentially bind to Alk3 and Alk6, while BMP-5, 
BMP-6, and BMP-7 bind Alk2. Similarly, there are three types of type II receptors that 
BMPs bind to: BMPR-II, ActR-II,7 and ActR-IIB (Miyazono et al. 251-63). 
SMADs are the signal transducers for the TGFp super-family. SMADs are divided 
into three categories based on their function: R-SMADs, Co-SMADs, and I-SMADs. R-
SMADs are pathway specific signal transducing SMADs which get phosphorylated in 
order to associate with Co-SMADs. These positive BMP mediators are SMAD1, SMAD5, 
and SMAD8. SMAD4 binds to all pathway-specific R-SMADs to create the R-SMAD/Co-
SMAD complex which translocates to the nucleus. Finally, the third type of SMADs is 
inhibitory and includes SMAD6 and SMAD7 which having an antagonizing influence on 
R-SMADs (Chang, Brown, and Matzuk 787-823; Miyazono et al. 251-63; Yamada et al. 
48-61). SMAD1 and SMAD5 are efficiently activated by BMP-6 and BMP-7, whereas all 
other BMP related R-SMADs are activated by BMP-2 (Miyazono et al. 251-63). 
Activin receptor-Like Kinase = Alk 
7 
Activin type II receptor 
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1.3. Heart Development and BMPs 
BMPs are vital regulators during cardiogenesis and early heart formation. A number 
of in vitro and genetic studies have shown that BMPs -2, -4, -5, -6, -7, -8, and -10 are 
involved in heart development. Mutations in BMP-2, BMP-4, Alk3, SMAD4, and SMAD5 
have resulted in early mortality in many mouse models during embryogenesis. Single 
mutations in mice in one of the genes encoding BMPs -5, -6, or -7 typically have mild 
consequences in heart formation. Double mutations, however, in BMP-5/BMP-7 or BMP-
6/BMP-7 can severely affect heart development (Delot 27-35). Table 1 presents a brief 
compilation of expression regions for various BMPs. To summarize, BMP-2 and -4 have 
important function throughout different development stages such that their expression 
pattern is seen in tissue that give rise to cardiac cushion, their components and myocardial 
regions (Table 1). More recent studies have shown that BMP-2 induces cell migration and 
periostin expression during atrioventricular valvulogenesis (Inai et al. 383-96). BMP-5, -
6, and -7 are also expressed widely and ubiquitously (Table 1). 
These BMPs may be partially redundant in comparison to BMPs -2 and -4; since a 
single knockout gene allows the maintenance of heart function (Delot 27-35; Chang, 
Brown, and Matzuk 787-823). Finally, BMP-10 appears to be limited to the trabeculae 
(Chang, Brown, and Matzuk 797; Gaussin et al. 2878). 
Periostin is a novel factor responsible for ventricular dilation. 
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Table 1. Expression Regions of Various BMPs in the Heart 
BMP-2 
BMP-4 
BMP-5 
BMP-6 
BMP-7 
BMP-10 
References 
Expressed at H&H stages 4-5 in lateral mesoderm adjacent to heart 
forming region (1) 
H&H stages 6-9 in pharyngeal endoderm underlying cardiogenic 
mesoderm (1) 
H&H stages 10-11 in sino-atrial region but absent from tubular heart 
itself (1) 
Expressed in Myocardial layers (2) 
Myocardium of endocardial cushion tissue-forming regions in 
spatiotemporally restricted manner (3) 
Expressed in the AV/OT myocardium, but not in the endocardium or 
mesenchymal cells (3) 
Expressed in the atrial-ventricular (AV) canal (4) 
In all stages, has always been expressed in muscularizing region, 
suggesting a role in late myocardium formation (5) 
Myocardium of endocardial cushion tissue-forming regions in 
spatiotemporally restricted manner (3) 
AV cushion (2) 
AV cushion (4) 
In all stages, has always been expressed in muscularizing region, 
suggesting a role in late myocardium formation (5) 
Initially homogenous throughout heart (2) 
Expressed homogenously in myocardium (4) 
Involved in late myocardium formation (5) 
Initially homogenous throughout heart (2) 
Expressed homogenously in myocardium (4) 
Mesenchymal cells (3) 
Involved in late myocardium formation (5) 
Initially homogenous throughout heart (2) 
Expressed homogenously in myocardium (4) 
Expressed at high levels ubiquitously throughout myocardium of mouse 
heart tube (6) 
In all stages, expressed throughout the entire myocardium. Doesn't 
seem to be involved in muscularization and septation. (5) 
Exclusively in trabeculae (2) 
Expressed exclusively in trabeculae (4) 
Chick 
Chick 
Chick 
Mouse 
Mouse 
Chick 
Mouse 
Chick 
Mouse 
Mouse 
Mouse 
Chick 
Mouse 
Mouse 
Chick 
Mouse 
Mouse 
Mouse 
Chick 
Mouse 
Mouse 
Mouse 
Chick 
Mouse 
Mouse 
l.(Schlangeetal. 259-70) 
2.(Gaussin et al. 2878-83) 
3.(Nakajimaetal. 119-27) 
4.(Chang, Brown and Matzuk 787-823) 
5.(Somietal. 636-51) 
6.(Delot 27-35) 
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Somi et al. mapped the expression patterns of BMP isoforms -2, -4, -5, -6, and -7 using 
in situ hybridization techniques (636-51). Their experiments establish where expected 
expression domains for BMPs -2, -4, -5, -6, and -7 are present during HH stages 10, 16, 24, 
and 30 (Fig. 3). 
The authors explain the spatial dispersion of expression as follows: 
In all stages analyzed BMP7 mRNA is expressed throughout the entire 
myocardium of the heart and therefore does not seem to be specifically 
involved in muscularization and septation. In vivo BMP2 and -4 mRNA are 
always present in the muscularizing regions, suggesting a role in late 
myocardium formation. However, in vitro BMP2 or BMP4 are not able to 
induce myocardium formation (van den Hoff et al., 2003), suggesting the 
involvement of additional factors. The fact that BMP5 mRNA is 
predominantly expressed in the cardiomyoctes that protrude into the BMP6 
mRNA expressing cushion mesenchyme suggests that BMP5 and -6 are 
involved in late myocardium formation as well. (Somi et al. 650) 
Thus far, the diversity of BMPs with their overlapping maps of expression suggests the 
utilization of BMP receptors to further complete and clarify the spatiotemporal expression 
domains of BMPs. Because BMP receptors are smaller in number and limited in valid 
heterodimeric permutations of type I and type II receptors, understanding their expression 
patterns during development may elucidate BMP roles in development. With their limited 
number, BMP receptors may interact with more than one ligand; and thus may have 
overlapping expression domains as well. 
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BMP2 BMP4 BMP5 BMP6 BMP7 
Myocardium Myocardium border ^ ^ B BMP staining Cushion tissue 
Figure 3. BMP-2, -4, -5, -6, and -7 Compared at Four Stages: This figure was reprinted 
with permission of Wiley-Liss, Inc. a subsidiary of John Wiley & Sons, Inc. The 
black/darker areas are the regions of BMP expression. Ea, embryonic atrium; ev, 
embryonic ventricle; cv, caval vein; IFT, inflow tract; ivs, interventricular septum; LV, left 
ventricle; LA, left atrium; mv, mitral valve; OFT, outflow tract; os, outlet septum; pv, 
pulmonary vein; RA, right atrium; RV, right ventricle; tv, tricuspid valve (Somi et al. 
2004). Note that BMP-7 is widely expressed in all stages, whereas BMP-6 is almost 
exclusively expressed in later stages of development. BMP-2 is mostly seen in 
myocardium throughout development. Chick embryonic Hamburger & Hamilton stages 
10, 16, 24, and 30 are 33-38 hours, 51-56 hours, 4.5 days, and 6.5-7 days respectively. 
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1.4. BMP Receptors in the Heart 
BMP receptors are limited in number, but there are over 15 types of known BMP 
ligands. It is more usual for receptors and their ligands to have a linearly corresponding 
relationship, such as insulin. It is likely that BMP receptors interact with more than one 
ligand and thus may have overlapping expression domains. Expression domains for BMP 
ligands in the chick heart are unique, but share regions in which they can overlap. How do 
corresponding BMP receptors correlate with respect to BMP expression domains? 
The activation of signal through the phosphorylation of type I receptor suggests that 
the specificity of the intracellular signal is mainly determined by these receptors as well. 
Two type I receptors that have been implicated to play critical roles in cardiogenesis are 
Alk2 and Alk3. Alk3 is almost ubiquitously expressed (Delot 27-35; Gaussin et al. 2878-
83) and knockout mice have defects in AV cushion formation, along with subsequent 
abnormalities in cardiac septa and valves (Chang, Brown, and Matzuk 787-823). 
The Alk2 receptor, also called ActRI, SKRI, Tsk-7L, ActRIA, or ACVR1 (Macias-
Silva et al. 25628-36; Chang, Brown, and Matzuk 787-823) has been reported to interact 
with BMPRII as its type II BMP receptor (Desgrosellier et al. 201-10) and has shown 
preference for BMP-7 as its ligand (Macias-Silva et al. 25628-36; Roelen et al. 541-9). In 
addition, Gaussin et al. have reported both BMP-6 and BMP-7 as the preferred ligands for 
Alk2 (2878-83). 
The expression and role of Alk2 in the developing heart using genetic models or in 
vitro experiments has been well studied. Antibody against chick Alk2 reduced epithelial-
to-mesenchymal transformation (EMT) in the atrioventricular cushions in vitro (Delot 27-
14 
35). Targeted ectopic expression of dominant negative Alk2 has been seen to affect heart 
looping (Shi et al. 226-37). Chang et al. reported that "Mouse embryos.. .homozygous for 
an Alk2 null mutation are arrested at early gastrulation with abnormal visceral endoderm 
morphology and severe disruption of mesoderm formation..." (793-6). 
Desgrosellier et al. concluded that Alk2 and SMAD6 regulate EMT during cardiac 
valve formation using in vitro and in vivo experiments (201-10). They have shown that in 
chicken embryos of HH stages 14-19, Alk2 mRNA is abundant in the OFT, ventricle, and 
AV cushion using in situ hybridization techniques: 
Expression was particularly abundant in endothelial cells comprising the 
endocardium of the heart. Expression of ALK2 was abundant in the OFT, 
ventricle, and AV cushion with a decrease in expression observed at the 
border between the AV cushion and the atria and between the OFT and the 
beginning of the aortic sac. Notably, little expression of ALK2 mRNA was 
observed in endothelial cells outside of the heart such as in the dorsal aorta. 
(203) 
Wang et al. concluded that Alk2 expression in endothelial cells plays a critical role in 
the early phases of endocardial cushion formation during cardiac morphogenesis in the 
mouse heart (299-310). Others have reported that Alk2 can mediate AV cushion 
transformation in chicken embryos (Lai et al. 1-11). Radioactive in situ hybridization on 
mice El 1.5 showed Alk2 expression by cardiac neural crest cells (Kaartinen et al. 3481-
90). 
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1.5. Why Study the Chick Heart? 
Historically, chick embryology dates back to 460-377 B.C. when Hippocrates used 
hens as incubators and cracked an egg open each day to check for change in development. 
William Harvery, 17' century physician and anatomist based some of his discoveries of 
heart formation and morphology changes on the chick's development in ovo (Bellairs and 
Osmond xxiii). 
There are many reasons that the chick is ideal to use for investigating heart formation 
and differentiation. The chick has a four chambered heart similar to mammals and has a 
short period of heart development of only about 4 days. Fertile eggs are cheap and 
available almost year-round. The genetics of the chick is well known and the genome has 
been sequenced. The chick is the only species with a four-chambered heart with less 
physiological complications, such as the absence of a placenta and embryo development in 
the mother. For these reasons, chick is an appealing model to use for studying heart 
development (Bellairs and Osmond xxiii-45). 
In this study, the mRNA for chick Alk2 was cloned, sequenced, and analyzed for 
splice sites. The Alk2 spatial expression pattern in the chick heart was determined using in 
situ hybridization during HH stage 18 (65-69 hours). 
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2. METHODOLOGY 
2.1. Purchase, Storage, and Incubation of Eggs 
Most initial work with embryos was from eggs purchased from our local Trader Joe's 
with an expiration date at least 3 weeks from the date of purchase to help ensure that the 
eggs were less aged. Older eggs would produce less reliable results. Detailed information 
about age of the eggs was not available; however, storage temperature for the eggs until 
purchase was noted to be at 7°C. Embryos were harvested and used throughout summer 
and fall. Unfortunately, abnormally cold temperatures in the winter had some sort of 
adverse affect on our egg fertility from Trader Joe's, resulting in no embryos from 
incubated eggs. Some embryos from Cal Cruz Hatchery in Santa Cruz, resulted in more 
reliable results of fertility and incubation periods. 
All eggs were incubated at 37.5°C in an incubator that held constant temperature with 
an internal fan to create a forced draft for uniform temperature within the incubator as well. 
A reservoir of water at the bottom of the incubator provided a humid environment for the 
eggs. A motor helped turn the eggs 90 degrees about every hour. 
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2.2. Harvesting, Fixation, and Dehydration 
After purchase, eggs were incubated at 37.5°C until desired stage of embryo was 
achieved (Fig. 4).9 After appropriate incubation times, each embryo was aseptically 
isolated, the embryo's chorioallantoic membrane was removed in sterile PBS, and the 
amniotic sac was dissected away. Embryos were then fixed in 4% paraformaldehyde 
(PFA) for 4 hours at 4°C and then dehydrated in a methanol gradient (10%, 30%, 50%, 
70%, and 90% for 10 minutes each) and stored in 100% methanol at 4°C until used for in 
situ hybridization. Embryos were roughly staged with respect to their morphology, gross 
anatomical features, and heart shape by two independent evaluators using a dissecting 
scope (8X) according to Hamburger & Hamilton. 
Figure 4. A 65-Hour Embryo prior to Isolation: Note that the heart is looped and 
numerous blood vessels have been established including the right and left 
omphalomesenteric arteries and the anterior and posterior omphalomesenteric veins. 
All embryos that were used for RNA isolation were 65-75 hours old. Embryos that were used for whole 
mount in situ hybridization were 65-69 hours. All figures reflect individual stages. Finally, embryos used 
for creating a serial map of sections of the chick heart were 72-80 hours old. 
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2.3. Whole Mount In Situ Hybridization 
In situ hybridization was performed using the protocol of Dr. Maya Purisai (personal 
communication) with some modifications and changes to adapt to our tissue type. The 
modified protocol consists of rehydration, washes, prehybridization, hybridization, washes, 
block, antibody incubation, washes, and finally color reagent. The detailed protocol is 
included in Appendix A. 
After dehydration, whole embryos were rehydrated in a methanol gradient (90%, 70%, 
50%, 30%, 10% for 10 minutes each) to prepare tissue for in situ hybridization. 
Subsequently, embryos were washed in PBS-T and 2X SSC at room temperature on a 
shaker for 15 and 10 minutes respectively. Embryos were then placed in 48-well plates and 
left static in prehybridization buffer at 68°C for 1 hour. A maximum of three embryos per 
well was used, such that embryos were completely submerged in prehybridization buffer 
during incubation. Lastly, embryos were placed in hybridization buffer with probe 
concentration of 0.5ug/mL at 68°C for overnight static incubation. This high temperature 
helps ensure specificity of our probe to the target mRNA. 
The following day, the embryos were removed from hybridization buffer and washed 
in 2X SSC and IX SSC each twice for 15 minutes at 37°C, followed by two washes of 
0.1X SSC at 37°C for 30 minutes each to reduce nonspecific reactions. These washes at 
high temperatures and salt concentration should allow for nonspecifically bound probes to 
become dislodged. All SSC washes were conducted on a shaker at 37°C, with 48-well 
plates covered and sealed with tape. 
19 
Next, the tissue was statically incubated in blocking solution (Appendix B) for 1 hour 
at room temperature, followed by 2 hours of incubation on a shaker at 37°C with anti-
digoxygenin antibody. Subsequently, the tissue was washed for 10 minutes each in Buffer 
1 and Buffer 2 (Appendix B) at room temperature on shaker. 
The sudden increase in pH from 7.5 of Buffer 1 to 9.5 of Buffer 2 prepares the tissue 
for its final incubation in BCIP/NBT alkaline phosphatase substrate solution for color 
development. Experimental and negative controls were placed in this BCIP/NBT solution, 
and finally stop solution or Buffer 3 (Appendix B). Incubation times in BCIP/NBT 
alkaline phosphatase substrate solution were monitored carefully to ensure consistent 
exposure of experimental and control tissue. 
Images were taken at 10X, 100X, and 200X using an Olympus CK40 compound 
inverted light microscope or dissecting microscope (8X). Embryos were then placed in 
100% methanol, after going through a methanol gradient, so that each embryo's stage of 
development could be reconfirmed. 
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2.4. Probe Construction 
Due to time constraints, the Alk2 receptor probe derived from a mouse sequence (ID # 
6418954/Accession # BC058718) was ordered from Open Biosystems and sent for 
sequencing (Sequetech, DNA Sequencing) for clone verification purposes.10 
Clones were provided as E. coli cultures in LB broth with 8% glycerol. Upon arrival, 
clones were allowed to grow in LB media at 37°C overnight and streaked on an LB/Amp 
plate until needed. One colony was picked from the plate and allowed to grow in 3ml of 
LB/Amp (lOOug/mL of Ampicilin in LB) at 37°C at 230 rpm for 6 hours, and 150 ul of the 
culture was added to 100 mL of fresh LB/Amp and incubated at 37°C at 230 rpm for 16 
hours. Cells were then pelleted by centrifuging for 10 minutes at 10,000 x g at 4°C. Cells 
were then resuspended in 3 ml of Cell Suspension Solution using the Wizard Plus 
Midipreps DNA Purification System (Promega). Plasmid DNA was extracted, purified, 
washed, eluted from column, and finally quantitated (Appendix C). 
RNA/DNA measurements in all experiments presented in this thesis were made using 
a NanoDrop spectrophotometer. It is important to note that the absolute quantity of DIG-
labeled probe may not be accurately measured with a NanoDrop. Since both our sense and 
antisense probes were measured using this spectrophotometer, however, it is sufficient to 
believe that our controls and experimental probes were subject to the same measurement 
device, and the small change in probe quantity does not adversely affect our in situ 
hybridization experiments. 
IMAGE Consortium (Lennon et al., 1996) [LLNL] cDNA clones: http://image.llnl.gov 
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EcoRl and Notl restriction enzymes were used for linearizing at the 5' and 3' ends 
respectively to make the antisense and sense probes (Fig5; Appendix D). 
Antisense 
EcoRl Notl EcoRl 
LJB5L ^ M - j * 
T7 T3 
-> <-
Insert = 1000 bp Vector =1690 bp 
Sense 
Notl EcoRl Notl 
13' 51 
* 
T3 T7 
~f <r 
Insert = 1000 bp Vector =1690 bp 
Figure 5. Template Linearization: Restriction enzyme digest using EcoRl (top) and Notl 
(bottom). These images help depict why T3 and T7 promoters were used for in vitro 
transcription of antisense and sense probes respectively. Note position of the insert with 
respect to its upstream and downstream promoters and restriction enzymes. 
Based on the plasmid map (Fig. 5) the appropriate enzymes, buffers, BSA, water, and 
plasmid DNA were assembled (Appendix E), mixed, and incubated at 37°C for 3 hours, 
before placing on ice to inactivate the enzyme. After linearization of plasmid, DNA was 
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precipitated and quantitated in order to proceed to in vitro transcription. Briefly, the 
procedure involved: addition of an equal volume of isopropanol, chilling at -20°C for 16 
hours, pelleting by centrifugation, washing pellet with 70% ethanol, pelleting, and finally 
air-drying. Pellet was resuspended in TE buffer to yield a concentration of 0.786 ug/ul of 
antisense and 0.24 ug/ul of sense linearized probe (Appendix E). Linearization of plasmid 
DNA was confirmed before proceeding to in vitro transcription on a 2% TAE based native 
agarose gel (Fig. 6). T3 and T7 promoters were selected for our antisense and sense probes 
for in vitro transcription. The appropriate enzymes, buffers, dNTPs, linearized template 
DNA, and water were assembled (Appendix E) and mixed. After 1 hour of incubation of 
the in vitro transcription reaction at 37°C, DNasel was added to the reaction to remove any 
template DNA and allowed to incubate at 37°C for 15 minutes. The RNA is then 
precipitated by addition of lA volume of lithium chloride and incubated at -20°C for 1 hour. 
Precipitated RNA is pelleted by centrifugation, washed with 70% ethanol, pelleted, and 
finally air-dried. Pellet was then resuspended in DEPC-treated water to yield 0.493 ug/ul 
and 0.445 ug/ul of antisense and sense Dig-UTP labeled probes respectively. Aliquots of 
Dig-UTP labeled probes in prehybridization buffer were made at a 0.5ug/mL and stored at -
80°C until needed (hybridization buffer). 
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2.5. Serial Sectioning 
Embryos were surgically isolated and fixed in 4% PFA at 4°C overnight. The next 
day, embryos were immersed in a phosphate buffered 10% sucrose solution (Appendix F) 
at 4°C for 1 day followed by an overnight static incubation in a phosphate buffered 30% 
sucrose solution (Appendix F) at 4°C. The following day, embryos were frozen on 
aluminum foil placed on dry ice and stored at -80° C until sectioned. The immersion in 
sucrose helps cryo-protect the tissue so that once frozen, the crystalline structures created 
by water do not damage the tissue, and it improves sectioning. 
Once the chamber temperature had been optimized to -30°C, serial sections were cut at 
100 um and 50 um for free floating in situ hybridization. 
Sections were then cut at 30 um at -30°C and gently placed on the warm surface of room-
temperature slides to enhance initial attachment. Different coated slides were used to test 
attachment including VWR superfrost slides, charged slides, poly-1-lysine coated slides, 
and silane coated slides.11 
Some embryos were surgically extracted, fixed in 4% PFA, dehydrated in a methanol 
gradient, and embedded in paraffin to create sections as thin as 10 um. Sections were then 
carried through a xylene gradient with methanol, followed by a paraffin gradient with 
xylene, until 100% paraffin was achieved (Appendix G). Tissue was cut at 10 um using a 
microtome and placed on a coated slide with Haupt's adhesive.12 
These slides are made with 3-aminopropyltriethoxysilane and are recommended for frozen sections. 
Manufacturer: Erie Scientific: (http://www.eriescientific.com, part number ER-298B, lot #199971). 
12 
This is a glycerine adhesive. Please refer to Dr. David Bruck in the Biological Sciences Department at San 
Jose State University for more detailed information on this adhesive. 
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2.6. Alk2 mRNA Sequence 
Embryos used for RNA isolation were 65-75 hours old. Embryos were collected and 
preserved in RNAlater until used. RNA was extracted from the embryos by 
homogenization of the tissue in a chaotropic denaturation solution, deproteination by 
extraction with Phenol:Chloroform:IAA followed by a second extraction in acid phenol to 
remove any contaminating genomic DNA (ToTALLY RNA Ambion kit; cat#1910).13 
RNA was precipitated by isopropanol, concentrated, washed, dried, resuspended, and 
finally quantified to yield 1.4 ug/ul. The integrity and overall quality of the RNA was 
evaluated by gel electrophoresis. After optimizing the RT-PCR by using the QIAGEN 
one-step RT-PCR kit (Appendix I), a step-down PCR program was used to increase 
performance and specificity (Appendix I). To gel purify PCR products, 5 ul of PCR 
product was electrophoresed on a 0.8% agarose gel and band-isolated using the QIAGEN 
MiniElute Gel Extraction kit (Appendix H). Briefly, the procedure involves band excision, 
addition of buffer QG based on gel weight, incubation at 50°C to dissolve gel, precipitation 
by isopropanol, washes with buffers QG and PE, and finally collection of DNA through 
elution in buffer EB and centrifugation on column. DNA was then quantified to yield a 
concentration of 16.4 ng/ul. 
The Alk2 chick cDNA was then cloned into a pCR®8/GW/TOPO vector from 
Invitrogen's pCR®8/GW/TOPO® TA Cloning® Kit (www.invitrogen.com). The 
procedure involved assembling a mixture of PCR product (4ul), Salt Solution (lul), and 
13 Please refer to Ambion's website for detailed protocol (www.ambion.com). 
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TOPO® Vector (lul). This cloning reaction was incubated at room temperature for 25 
minutes and 2 ul from the cloning reaction was added into a vial of One Shot® chemically 
competent E. coli and allowed to incubate on ice for 10 minutes. Cells were heat-shocked 
for 30 seconds at 42°C and placed on ice until 250 ul of S.O.C. medium 
(pCR®8/GW/TOPO® TA Cloning® Kit) was added to the mixture. The cells were 
incubated at 37°C for 1 hour with shaking. The bacterial culture was then spread on pre-
warmed LB agar plates containing 100 ug/mL spectinomycin and allowed to incubate 
overnight at 37°C. 
Thirteen colonies from the transformed cells were picked and grown in individual 
flasks of LB containing 100 ug/mL of spectinomycin. The QIAprep Spin Miniprep kit was 
used to isolate plasmid (http://wwwl.qiagen.com/; cat# 27104). Using their protocol, 
plasmid DNA was extracted, purified, washed, eluted from column, and finally quantitated. 
After quantification of plasmid DNA, the four best quality clones were sent for sequencing 
(Sequetech, DNA Sequencing) to find a distinct cDNA sequence at this developmental 
stage and compare it to chick genomic DNA for selection of unique splice sites. 
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3. RESULTS 
3.1. Probe Construction 
After probe linearization, a 1% agarose gel was run for confirmation (Fig. 6). 
r 
10kB 
6kB 
High DNA mass ladder J „ , „ 
> 3kB 
2kB 
V. 
Supercoiled, non-linearized Plasmid 
at high molecular weight 
< Linearized Alk2 cut with Notl 
running at about 4.5 kB 
< Linearized Alk2 cut with EcoRl at 
two different sites running at about 
2.1kBand2.3kB 
Figure 6. Gel Confirming Linearization of Plasmid DNA: Lane 1: high DNA mass ladder, 
lane 2: super-coiled uncut plasmid DNA, lane 3: linearized Alk2 plasmid cut with EcoRl, 
lane 4: linearized plasmid cut with Notl restriction enzyme. Super-coiled plasmid DNA 
usually migrates faster than linearized plasmid, however, the results here have been found 
reproducible and consistent. 
The Alk2 plasmid (from Open Biosystems) sequence was compared with the chicken 
Alk2 from NCBI by a BLAST and was found to be 99% similar (Fig. 8). Alignment of the 
chicken CDS from NCBI (presented in blue font) and the sequenced results of the Open 
Biosystems mouse probe (shown in orange font) show that the two sequences are almost 
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identical in overlapping regions (Fig. 7). The alignment indicates that the mouse probe is 
almost identical to the chicken cDNA, and should be suitable as a probe for in situ 
hybridization. 
It is important to note that only a portion of the entire Alk2 CDS region from mouse 
BC058718 was incorporated into the plasmid from Open Biosystems. This segment was 
1000 base pairs which should have sufficient permeability and specificity in our probing 
system. 
In the multiple sequence alignment presented here, the stars represent identity in the 
two sequences. This alignment also shows potential nucleotide gaps, point mutations, 
deletions, or insertions. 
NCBI_Chicken_Alk2 
OpenBiosystems_Mouse_Alk2 
ATGGCTCTCCCCGTGCTGCTGCTGCTGCTGGCCCTGCCATCCCGCAGTGT 
GGGATGGGGTACGCCATGCTGCAG-AC 
* ** ***** * **** 
NCBI_Chi cken_Alk2 
OpenBiosystems_Mouse_Aik2 
GCAAGATGAGGAGCTGAAGCTAAATGAATGTGTGTGTGAAGGCATGTCAT 
GC GTTACGTATCGGATCCAGA ATTCGTGAT TGTCAT 
** *** * * * * * * **** ****** 
NCBI_Chicken_Alk2 
OpenBiosystems_Mouse_Alk.2 
GTGGGAATGGAGACCGCTGCCAGGGCCAGCAGTGCTTCGCCTCCCTGAGC 
GTGGGAATGGAGACCGCTGCCAGGGCCAGCAGTGCTTCGCCTCCCTGAGC 
************************************************** 
NCBI_Chicken_Alk2 
OpenBi osystems__Mouse_Alk2 
ATTAACGATGGTGCTAAGGTTTACCAGAAAGGCTGCTTCCAAGTCTATGA 
ATTAGCGATGGTGCTAAGGTTTAGCAGAAAGGCTGCTTCCAAGTCTATGA 
**** ********************************************* 
NCBI_Chicken_Alk2 
OpenBiosyst.ems_Mouse_Alk2 
ACAAGGGAAAATGACGTGCAAAACTCCGCCATCTCCTGACCAAGCTGTGG 
ACAAGGGAAAATGACGTGCAAAACTCCGCCATCTCCTGACCAAGCTGTGG 
************************************************** 
NCBI_Chicken_Alk2 
OpenBiosystems__Mouse_Alk2 
AGTGCTGCCAAGGATACCTTTGCAACATGAATATCACTGCGAAGTTGCCC 
AGTGCTGCCAAGGATACCTTTGCAACATGAATATCACTGTGAAGTTGCCC 
*************************************** ********** 
NCBI_Chicken_Alk2 
OpenBi osysteins_Mouse_Aik2 
TCTTCTAAAGGGCAAACCCTGCAAGGGGAAGCTGCAGGTTACAGCATGGA 
TCTTCTAAAGGGCAAACCCTGCAAGGGGAAGCTGCAGGTTACAGCATGGA 
************************************************** 
NCBI_Chicken_Alk2 
OpenBi osystems_Mouse_Alk2 
AACACTAATCATCGTTATACTGGCTCCTGTAGTAGTGCTGGTAATTTTCT 
AACACTAATCATCGTTATACTGGCTCCTGTAGTAGTGCTGGTAATTTTCT 
************************************************** 
NCBI_Chicken_Alk2 
OpenBiosystems_Mouse_Alk2 
CTGTGGTAGCTGTGCTCATCATCCGGAGGATACAGAAGAACCACATGGAG 
CTGTGGTAGCTGTGCTCATCATCCGGAGGATACAGAAGAACCACATGGAG 
************************************************** 
NCBI_Chicken_Alk2 
OpenBiosystems_Mouse _Alk2 
AGACTCAATTCTAGAGATGCAGAATATGGCACAATTGAGGGACTCATTGC 
AGACTCAATTCTAGAGATGCAGAATATGGCAGAATTGAGGGACTCATTGC 
************************************************** 
NCBI_Chicken_Alk2 
OpenBiosysLems Mouse Alk2 
TTCAAATGTTGGAGACAGTACATTGGCAGATTTATTGGACCATTCCTGCA 
TTCAAATGTTGGAGACAGTACATTGGCAGATTTATTGGACCATTCCTGCA 
************************************************** 
NCBI_Chicken_Alk2 
OpenBi osystems_Mouse_A.Lk2 
CATCTGGAAGTGGTTCTGGACTTCCATTCTTGGTGCAAAGAACAGTGGCT 
CATCTGGAAGTGGTTCTGGACTTCCATTCTTGGTGCAAAGAACAGTGGCT 
************************************************** 
NCBI_Chicken_Alk2 
OpenBiosystems_Mou.se Alk2 
CGCCAGATCACGCTTGTGGAGTGTGTAGGAAAGGGCCGTTATGGAGAAGT 
CGCCAGATCACGCTTGTGGAGTGTGTAGGAAAGGGCCGTTATGGACAACT 
*********************** 
NCBI_Chicken_Alk2 
OpenBiosysLems _Mouse__Alk2 
CTGGAGGGGTCAGTGGCAAGGAGAGAATGTTGCTGTGAAGATCTTCTCTT 
CTGGAGGGGTCAGTGGCAAGGAGAGAATGTTGCTGTGAAGATCTTCTCTT 
************************************************** 
NCBI_Chicken_Alk2 
OpenBi osyst.ems_Mouse_Aik2 
CTAGGGATGAAAAATCCTGGTTCAGGGAAACTGAATTGTATAACACTGTG 
CTAGGGATGAAAAATCCTGGTTCAGGGAAACTGAATTGTATAACACTGTG 
NCBI_Chicken_Alk2 
OpenBiosystems Mouse Alk2 
TTGCTGCGGCATGAAAACATTTTAGGTTTTATTGCATCCGATATGACTTC 
TTGCTGCGGCATGAAAACACTTTAGGTTTTATTGCATCCGATATGACTTC 
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NCBI_Chicken_Alk2 
OpenBiosystems_Mouse_Alk2 
NCBI_Chicken_Alk2 
OpenBiosystems_Mouse__Alk2 
NCBI_Chicken_Alk2 
OpenBiosystems_Mouse Alk2 
NCBI_Chicken_Alk2 
OpenBiosystems_Mouse_Alk2 
NCBI_Chicken_Alk2 
OpenBiosystems_Mouse_Alk2 
NCBI_Chicken_Alk2 
OpenBiosystems_Mouse Alk2 
NCBI_Chicken_Alk2 
OpenBiosysLemsJMouse_Alk2 
NCBI_Chicken_Alk2 
OpenBiosystems__Mouse Alk2 
NCBI_Chicken_Alk2 
OpenBiosystems__Mouse_Alk2 
NCBI_Chi cken_Alk2 
OpenBiosystems_Mouse_A.l. k2 
NCBI_Chicken_Alk2 
OpenBiosystems__Mouse_Alk2 
NCBI_Chi cken_Alk2 
OpenBiosystems_Mouse_Alk2 
NCBI_Chicken_Alk2 
OpenBiosystems_Mouse_Alk2 
NCBI_Chicken_Alk2 
OpenBiosystems__Mouse_Alk2 
NCBI_Chicken_Alk2 
OpenBiosystems_Mouse_Alk2 
CAGAAACTCTAGCACCCAGCTGTGGCTAATTACTCACTACCACGAGATGG 
CAGAAACTCTAGCACCCAGCTGTGGCTAATTACTCACTACCACGAGATGG 
************************************************** 
GGTCTTTGTATGACTATCTGCAGCTCACCACCCTGGACACTGTCAGCTGC 
GGTCTTTGTATGACTATCTGCAGCTCACCACCCTGGACACTGTCAGCTGC 
************************************************** 
CTGCGGATAGTACTGTCCATAGCCAGCGGCCTTGCACATTTGCACATAGA 
CTGCGGATAGTACTGTC-ATAGCCAGCGGCCTTGCACATTTGCACATAGA 
***************** ******************************** 
GATATTTGGAACGCAGGGGAAGCCTGCCATTTCTCATCGGGACTTGAAGA 
GATATTTGGA-CGCAGGG—AGCCTGC-ATTTCTCATCGGGACTTGA-GA 
********** ******* ******* ******************* ** 
GCAAAAATATCCTTGTTAAGAAAAATGGACAGTGCTGCATAGCAGACTTA 
GCAAAA-TATCTTT AAGAAATGACAGTGCTGCATAGCAGACTAG 
****** **** ** ** ** ********************* 
GGCCTCGCAGTCATGCACTCCCAAAGCACGAACCAGTTGGATGTGGGGAA 
c 
CAACCCCCGAGTGGGCACCAAACGCTACATGGCTCCGGAGGTCTTGGACG 
AAACCATCCAGGCAGACTGCTTCGACTCCTACAAGAGGGTCGATATCTGG 
GCCTTCGGGCTGGTCCTGTGGGAGGTAGCTAGGCGCATGGTTAGCAATGG 
TATTGTAGAAGACTATAAACCACCATTTTATGACCTGGTTCCAAATGATC 
CCAGTTTTGAAGACATGAGGAAAGTGGTCTGTGTAGATCAGCAAAGGCCA 
AACATTCCCAACAGGTGGTTCTCAGACCCTACATTAACATCTCTTGCCAA 
GTTGATGAAAGAATGCTGGTATCAGAATCCATCAGCAAGACTAACAGCCC 
TGCGAATCAAAAAGACTTTGACCAAAATTGATAATTCCTTAGATAAACTG 
AAGGCTGACTGTTGA 
Figure 7. Multiple Sequence Alignment of Alk2 in Chick and Mouse: CLUSTAL W 
(1.81) of chicken Alk2 from NCBI with mouse Alk2 from Open Biosystems using an 
alignment program (http://align.genome.jp/)-
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The chicken CDS and sequenced mouse Open Biosystems probe are 99% similar 
(NCBI BLAST).14 
Sequence l:lcl|l 
Length* 1515(1 .1515) 
Sequence 2: lcl|65536 
Length= 1000(1 ..1000) 
NOTE:Bitscore and expect value are calculated based on die size of the nr database. 
NOTEJfprotdn translation is reversed, please repeat the search with reverse strand of the query sequence. 
Score « 1654 bi ts (860), Expect « 0.0 
I d e n t i t i e s - 903/912 (99%>, Gaps - 6/912 (0%) 
Strand»Plu*/Plus 
Figure 8. Comparison of Chick and Mouse Alk2 Using BLAST: Comparison of chicken 
Alk2 cDNA from NCBI and mouse Alk2 cDNA from Open Biosystems. The BLAST 
result indicates 99% identity between the mouse and chicken Alk2 cDNA sequences. This 
confirms that the mouse probe from Open Biosystems is a reasonable substitute for the 
chick Alk2. 
NCBI BLAST software can be found at http://www.ncbi.nlm.nih.gov/blast/bl2seq/wblast2.cgi. 
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3.2. Serial Sectioning 
Frozen sections were cut in a cold cryostat at lOOum and 50 um thicknesses for free 
floating in situ hybridization. Due to the watery nature of tissue, however, these sections 
were all torn during the first initial washes before in situ hybridization. The 30 um sections 
that were similarly made and attached to VWR superfrost slides, charged slides, poly-1-
lysine coated slides, and silane coated slides were ineffective as well. All sections were 
detached from the coated slide during the initial wash steps before in situ hybridization. 
Paraffin embedded embryos were also inadequate as after hybridization at high 
temperatures such as 68°C. Since all these sections detached from the slides, whole mount 
in situ hybridization was pursued, and the remaining unused sectioned embryos were used 
to create a reference map for the differentiating heart, resulting in 45 sagittal sections that 
are nearly consecutive (Fig. 9). 
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Figure 9. Serial Sections of the Chick Heart: Taken from a 72-80-hour embryo as a 
reference map for the differentiating heart. Sections were cut 30 um in thickness, stained 
with cresyl violet, and imaged with 10X dissecting scope. Reference numbers show 
section ordering as some sections were lost due to detachment during staining. 
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3.3. Whole Mount In Situ Hybridization 
Whole mount in situ hybridization was conducted using the techniques described in 
Methods. Tissue was probed with DIG-labeled sense or antisense Alk2 receptor RNA (Fig. 
10 and Fig. 11). No hybridization occurred in control tissue probed with sense RNA (Fig. 
IOC, 10D, 1II, and 11 J). In addition, the specificity of the anti-DIG antibody was 
confirmed using hybridizations lacking probe (Fig. 10A and Fig. 10B). 
Antisense probes produce and intense signal that indicates the presence of Alk2 receptor 
mRNA in heart tissue (Fig. 10E-10H and Fig. 1 IK-1 IP). 
Note that in all antisense embryos (Fig. 10E-10H and Fig. 1 IK-1 IP) the hybridization 
seems to be distinctly occurring in the developing interventricular septa and/or in the 
membraneous septa of the outflow tracks. 
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Figure 10. Whole Mount In Situ Hybridization on Chick Embryos (Part 1): Panels A, B, 
C, and D are negative controls showing the lack of non-specific hybridization of the anti-
DIG antibody and the specific binding of the Alk2 receptor probe to the mRNA and not the 
genomic DNA. Panels E, F, G, and H are examples of specific hybridization of the Alk2 
receptor probe to its mRNA complement in regions such as the outflow tract and atrium. 
Note that these embryos are at H&H stage 18. 
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Figure 11. Whole Mount In Situ Hybridization on Chick Embryos (Part 2): Panels I and J 
depict another embryo probed with sense RNA as a negative control. Similar to figures IOC 
and 10D, no hybridization is seen in any of the heart regions; indicating that the Alk2 
receptor probe is hybridizing to the mRNA in the target tissue. Panels K, L, M, N, O, and 
P depict embryos that were probed with the antisense Alk2 receptor DIG-labeled RNA. As 
shown by the white arrows, panels L and N show hybridization in regions such as the 
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outflow tract and atrium. Panel P depicts hybridization to ventricular regions. There also 
seems to be some signal depicted in the eye in panel P. This phenomenon was also seen in 
other embryos, such that 20% of all antisense embryos had some sort of signal in their eye. 
Note that these embryos are at H&H stage 18. Appendix A was followed for in situ 
hybridization protocol. 
3.4. Alk2 mRNA Sequence 
The image below is a 1% native agarose gel to confirm RNA quality before RT-PCR. 
It is important to note that the 28S/18S bands are too broad to rule out degradation.15 
Figure 12. Native Agarose Gel on Chick Total RNA: A 1% native agarose gel was used to 
assess quality and location of 18S/28S RNA bands. For better depiction, a formaldehyde 
gel should be employed as a native gel cannot clearly depict the true molecular weight of 
an RNA structure due to its double stranded secondary structure. The apparent molecular 
weight of the 28S and 18S bands are 1.5 kB and 700 bp respectively. This is a good 
correlation to what Kim et al. have stated.16 
Due to time constraints, the Open Biosystems mouse Alk2 cDNA was utilized as the probe for in situ 
hybridization. Once the chick RNA was isolated, we decided to examine the uniqueness of the cDNA 
sequence. 
This article (Kim et al. 1473-80) shows that for chicken, the 28S and 18S bands are at 2.6 kB and 1.8 kB 
respectively. These numbers can be correlated to the apparent molecular weight of the 28S/18S bands 
(Figure 12). The displacement in these bands could be due to the migration differences in a denaturing 
formaldehyde gel to a native agarose gel. 
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Optimized RT-PCR amplified 3 bands on gel electrophoresis (Fig. 13). The circled band 
was extracted and gel purified. 
lOObp lkB 5ulPCR low mass 
ladder ladder product ladder 
1000 bp 
. 2000 bp 
1517bp. " 
1200 bp • • • ^ 1 2 0 0 bp 
• 800 bp 
Figure 13. Native Agarose Gel on Alk2 PCR Product: The 0.8% agarose gel with 
corresponding standards indicates a 1361bp band in the PCR product lane at the expected 
length for excision. 
The resulting band was cloned into the TOPO vector and sent for sequence analysis 
(Appendix J). The resulting sequence was aligned17 with chicken CDS sequence from 
1 Q 
NCBI. Alignment results indicate that other than small anomalies such as two bases 
(which are likely due to sequencing errors) the two sequences are identical (Fig. 14). Since 
our cDNA sequence matched exactly with that of NCBI, it is not a novel cDNA isoform; 
and therefore it's unlikely that we can find novel splice sites. 
17 
http://align.genome.jp/ 
18NM 204560 
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ATGGCTCTCCCCGTGCTGCTGCTGCTGCTGGCCCTGCCATCCCGCAGTGT 
GCAAGATGAGGAGCTGAAGCTAAATGAATGTGTGTGTGAAGGCATGTCAT 
** *** 
GTGGGAATGGAGACCGCTGCCAGGGCCAGCAGTGCTTCGCCTCCCTGAGC 
GTGGGAATGGAGACCGCTGCCACGGCCAGCAGTGCTTCCCCTCCCTGAGC 
****** ************************************* ******* 
ATTAACGATGGTGCTAAGGTTTACCAGAAAGGCTGCTTCCAAGTCTATGA 
ATTAACGATGGTGCTAAGGTTTACCAGAAAGGCTGCTTCCAAGTCTATGA 
************************************************** 
ACAAGGGAAAATGACGTGCAAAACTCCGCCATCTCCTGACCAAGCTGTGG 
ACAACIXAAAATGACCTGCAAAACTCCCCTATmrTCACCAACCTCTCG 
************************************************** 
AGTGCTGCCAAGGATACCTTTGCAACATGAATATCACTGCGAAGTTGCCC 
AGTGCTGCCAAGGATACCTTTGCAACATGAATATCACTCCGAACTTGCCC 
************************************************** 
TCTTCTAAAGGGCAAACCCTGCAAGGGGAAGCTGCAGGTTACAGCATGGA 
TCTTCTAAACGGCAAACCCTGCAAGGGCAACCTGCAGCTTACAOCATGGA 
************************************************** 
AACACTAATCATCGTTATACTGGCTCCTGTAGTAGTGCTGGTAATTTTCT 
AACACTAATCATCCTTATACTCGCTCCTCTAGTACTCCTCGTAATTTTCT 
************************************************** 
CTGTGGTAGCTGTGCTCATCATCCGGAGGATACAGAAGAACCACATGGAG 
CTGTGCTACCTCTGCTCATCATCCGGAGGATACACAAGAACCACATGCAC 
AGACTCAATTCTAGAGATGCAGAATATGGCACAATTGAGGGACTCATTGC 
AGACTCAATTCTAGAGATGCAGAATATGGCACAATTCACGGACTCATTGC 
************************************************** 
TTCAAATGTTGGAGACAGTACATTGGCAGATTTATTGGACCATTCCTGCA 
TTCAAATGTTGGAGACAGTACATTGGCACATTTATTGCAC(':ATTCCTGCA 
************************************************** 
CATCTGGAAGTGGTTCTGGACTTCCATTCTTGGTGCAAAGAACAGTGGCT 
CATCTGGAAGTGGTTCTGGACTTCGATTCTTGGTGCAAAGAACAGTGGCT 
************************************************** 
CGCCAGATCACGCTTGTGGAGTGTGTAGGAAAGGGCCGTTATGGAGAAGT 
CGCCAGATCACGCTTGTGGAGTGTGTAGGAAAGGCCCGTTATGGAGAAGT 
******************* *************** 
CTGGAGGGGTCAGTGGCAAGGAGAGAATGTTGCTGTGAAGATCTTCTCTT 
CTGGAGGGCTCAGTGGCAAGGAGAGAATGTTGCTGTGAAGATCTTCTCTT 
*************** **************** 
CTAGGGATGAAAAATCCTGGTTCAGGGAAACTGAATTGTATAACACTGTG 
CTAGGGATGAAAAATCCTGGTTCAGGGAAACTGAATTGTATAACACTGTG 
TTGCTGCGGCATGAAAACATTTTAGGTTTTATTGCATCCGATATGACTTC 
TTGCTGCGGCATGAAAACATTTTAGCTTTTATTCCATCCGATATCACTTC 
************************************************** 
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CAGAAACTCTAGCACCCAGCTGTGGCTAATTACTCACTACCACGAGATGG 
CAGAAACTCTAGCACCCAGCTGTGGCTAATTACTCA(.:TACCAC-AGAT('X; 
****************************************** ****** 
GGTCTTTGTATGACTATCTGCAGCTCACCACCCTGGACACTGTCAGCTGC 
GCTCTTTGTATGACTATCTGCAGCTCACCACCCTGGACACTGTCAGCTCC 
************************************************** 
CTGCGGATAGTACTGTCCATAGCCAGCGGCCTTGCACATTTGCACATAGA 
CTGCGCATACTACTGTCCATAGCCAGCGGCCTTGCACATTTCCACATAGA 
************************************************** 
GATATTTGGAACGCAGGGGAAGCCTGCCATTTCTCATCGGGACTTGAAGA 
CATATTTGOAACCCAGGGGAAGCCTCCOATTTCTCATCGGGACTTGAAGA 
************************************************** 
GCAAAAATATCCTTGTTAAGAAAAATGGACAGTGCTGCATAGCAGACTTA 
GCAAAAATATCC'n'GTTAACAAAAATGGACACTGCTGCATAGCAGACTTA 
************************************************** 
GGCCTCGCAGTCATGCACTCCCAAAGCACGAACCAGTTGGATGTGGGGAA 
GGCCTCGCAGTCATCCACTCCCAAAGCACCAACCAGTTCCATGTGGCGAA 
************************************************** 
CAACCCCCGAGTGGGCACCAAACGCTACATGGCTCCGGAGGTCTTGGACG 
CAACCCCCGACTGCGCACCAAACGCTACATGGCTCCGGAGGTCTTCCACG 
************************************************** 
AAACCATCCAGGCAGACTGCTTCGACTCCTACAAGAGGGTCGATATCTGG 
AAACCATCCACGCACACTGCTTCCACTCCTACAACACGGTCCATATCTGC 
************************************************** 
GCCTTCGGGCTGGTCCTGTGGGAGGTAGCTAGGCGCATGGTTAGCAATGG 
GCXJTTCGGCCTCCTCCTGTCGGACCTAGCTAGCCGCA'J'CCTTACCAATCC 
TATTGTAGAAGACTATAAACCACCATTTTATGACCTGGTTCCAAATGATC 
TATTCTAGAAGACTATAAACCACCATTTTATCACCTCljTTCCAAATCATC 
************************************************** 
CCAGTTTTGAAGACATGAGGAAAGTGGTCTGTGTAGATCAGCAAAGGCCA 
CCAGTTTTGAAGACATGAGGAAAGTGCTCTGTGTAGATCAGCAAAGGCCA 
************************************************** 
AACATTCCCAACAGGTGGTTCTCAGACCCTACATTAACATCTCTTGCCAA 
AACATTCCCAACAGGTGGTTCTCAGACCCTAC:ATTAACATCTCTTGCCAA 
************************************************** 
GTTGATGAAAGAATGCTGGTATCAGAATCCATCAGCAAGACTAACAGCCC 
GTTCATGAAACAATCCTGGTATCAGAATCCATCACCAAGACTAACAGCCC 
************************************************** 
TGCGAATCAAAAAGACTTTGACCAAAATTGATAATTCCTTAGATAAACTG 
rGCGAA--
AAGGCTGACTGTTGA 
Figure 14. Multiple Sequence Alignment of Alk2 Sequences: CLUSTAL W (1.81) of chicken 
Alk2 from NCBI with Alk2 cDNA from stage 18 embryos using an alignment program 
(http://align.genome.jp). 
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4. DISCUSSION 
Since the ability of BMP to transmit an intracellular signal ultimately occurs through 
the phosphorylation of type I receptors, the specificity of the intracellular signal is mainly 
determined by these receptors. Alk2 is a type I receptor that has been suggested to be 
present in the OFT, ventricles, and AV cushion (Desgrosellier 201-10). In spite of the 
many problems associated with whole mount early stage embryo in situ hybridization (the 
intrinsic fragility of the embryo, the difficulty in removing closely associated membranes, 
optimization of the hybridization conditions, non-specific entrapment of the probe and/or 
antibody conjugates in tissue mass, the optimization of treatments that increase tissue 
permeability while still preserving tissue morphology etc), we were able to detect 
consistent signal in the outflow tract and regions of the atria and ventricles. 
We are struck, however, by the apparent discrepancies between the BMP expression 
domain models proposed by Somi et al. and Alk2 expression domains we identified here 
(648). At embryonic stage HH16, for example, the expression model proposed by Somi et 
al. indicates that BMP5 and 7 are expressed essentially throughout the entire myocardium 
(Fig. 3). The embryos we examined in the stage HH16-18 range displayed a more 
restricted expression domain for Alk2. BMP7 is widely believed to be a ligand that 
preferentially binds to Alk2 (Macias-Silva et al. 25628-36; Roelen et al. 541-9). Why then 
is the entire heart bathed in this BMP while so little of the heart able to respond to it? This 
difference in expression domains presents a number of interesting questions. Are there 
other Alk2 isoforms expressed throughout the heart that our probe did not detect? Those 
different Alk2 isoforms might then confer BMP responsiveness for those regions of the 
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heart outside of the Alk2 expression domain we identified. Are other non-Alk2 BMP 
receptors expressed in those BMP domains that might confer responsiveness? Is it possible 
that large sections of the heart do not express BMP receptors and really are unresponsive to 
these BMPs, despite producing them? Are the broad expression domains presented by 
Somi et al. misleading due to non-specific hybridization and/or probe entrapment? Are the 
more restrictive expression domains we have found for Alk2 themselves artifactually small 
due to limitations in probe accessibility during hybridization and/or the use of overly 
stringent hybridization conditions? 
Isoforms of Alk2 (and possibly other BMP receptors) might be present and abundant 
enough to amplify out from total chick heart mRNA using our primers and RT-PCR 
protocol. While we were successful in amplifying and cloning one Alk2 cDNA, it turned 
out to be the same isoform in the NCBI database. This does not rule out, however, the 
possibility that other isoforms exist. We noted 3 different amplified products present which 
could be different isoforms of Alk2 (Fig. 13, lane 3). Due to its size, and higher 
abundance, we only cloned the one PCR product (Fig. 13). Although it is likely that these 
extra bands may be reaction by-products, due to the RNA's secondary structure when the 
polymerase reached regions of non-linearity, their importance was not evaluated. 
Undescribed isoforms could be elucidated any number of ways, including modifications to 
our primer design, changing the RT-PCR cycling conditions, and screening Northern blots 
of chick heart mRNA under conditions of low stringency. 
In addition, there is a discrepancy in the literature regarding which BMPs interact with 
Alk2. Some have found that BMPs -2, -4, and -7 (Kishigami and Mishina 265-78) are the 
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interacting ligands, while others have reported BMPs -6 and -7 (Gaussin et al. 2878-83). 
Some references have referred to BMP-7 as the only Alk2 ligand (Macias-Silva et al. 
25628-36; Roelen et al. 541-9). Therefore, our results may be interpreted differently, based 
on which BMPs actually interacts with Alk2. For example, Somi et al. found (Fig. 3) that 
during HH16, BMPs -5 and -7 are widely expressed, while, BMPs -2 and -4 are only 
expressed in small regions of the outflow tract and AV cushion (only BMP-2). BMP-6 
expression is not present during this stage of development (648). If Alk2 is indeed the 
receptor for BMPs -2 and -4, then based on our results, why is its expression seen more 
abundantly (atrium, ventricle, and outflow tract) than its corresponding ligands? Similarly, 
if BMPs -6 or -7 are so widely expressed, then why are its receptors so restricted? 
Finding reliable expression domains is experimentally difficult to address. In order to 
provide convincing evidence that any signal is in fact specific one must establish a large 
group of experimental replicates and, ideally, hybridize using a family of target-specific 
probes of various lengths. The latter approach would help define both the maximum probe 
length capable of ensuring probe permeability while still maintaining adequate signal 
strength, and the minimum probe length required to maintain signal specificity. 
Examination of the probe sequence through bioinformatics programs will ensure that cross-
hybridization to mRNAs of other family members does not occur. Whole mount in situ 
hybridization has limitations. The presence of heavy cartilage, abundant extracellular 
matrix or thick basement membranes, may limit the ability of the hybridization probe (or 
subsequent antibodies) to gain access to the target mRNAs. A number of techniques can be 
used to increase permeability such as incubation times, proteinase K digestion, and smaller 
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probe sizes. The use of cross-linking fixatives such as PFA, methanol dehydration steps, 
and incubation at high temperatures with 50% formamide solutions may have the ability to 
damage the tissue or render at least some fraction of the target mRNA molecules 
unavailable for hybridization (via degradation, aggregation and/or complex formation with 
proteins or other macromolecules). These conditions may then produce some reduction in 
signal strength. In order to determine the extent of signal reduction, one can surgically 
isolate embryos and proceed to in situ hybridization on the same day, so as to remove the 
dehydration steps. This task will be labor intensive, but may yield informative results. 
Quantitative RT-PCR could be used to determine the presence and relative abundance 
of Alk2 mRNA in various regions of the heart tube and compared to in situ data. 
Interpreting staining patterns was sometimes difficult due to tissue damage during embryo 
manipulation. Enhancing signal strength a variety of modifications can be made to our 
current protocol. Tissue digestion with proteinase K will increase permeability of probe, 
but also make tissue more fragile. Increasing the probe concentration from 0.5 ug/mL to 1 
or 2 ug/mL and overnight incubation of the color reaction will increase signal strength, but 
may cause over-staining and non-specific reactions. 
Probe size must also be carefully considered. Longer probes provide increased 
specificity, but have more permeability problems. Our probe from Open Biosystems was 
1000 base pairs compared to published methods that recommend a range of 300 to 750 
base pairs for in situ hybridization probes. It is plausible that a smaller probe would more 
easily hybridize to less abundant message, and this can be tested by hydrolyzing probe into 
smaller fragments. Increasing hybridization temperature can also help increase specificity 
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of signal, and decrease nonspecific hybridization. Moorman et al. found that increasing 
hybridization temperature also helps increase permeability of tissue (1-8). Some protocols 
call for more washes at higher temperatures post-hybridization to decrease non-specificity. 
Using sections instead of whole embryos will inherently help the signal quality, as 
sections will not entrap probe or antibody as membranous tissue might. Radioactive in situ 
hybridization allows for more specific signal, as radioactive probes are directly responsible 
for signal, but increases protocol complexity. 
We also tried sectioning embryos after whole mount in situ hybridization; so that we 
could interpret the signal from two different viewpoints. After whole mount in situ 
hybridization, tissue was dehydrated and paraffin embedded as outlined in Appendix G. 
Upon sectioning with microtome, however, we found that the tissue shattered and did not 
remain intact. This could be due to residual formamide still trapped in the tissue from the 
prehybridization and hybridization steps. 
The native agarose gel (Fig. 12) used to estimate RNA quality showed some RNA 
degradation due indicated by the breadth of the 28S and 18S bands. The quality of this 
RNA that was used in a one-step RT-PCR reaction, may imply the need for RT-PCR 
optimization. There was discrepancy of 2 base pairs between the chick cDNA sequence 
that we extracted from RT-PCR and sent for sequencing and NCBI's chick CDS. This 
discrepancy may be from small base-pair sequencing errors. 
Finally, one of the most challenging tasks was finding optimum attachment conditions 
such that the watery tissue could be sectioned and completely attached to its microscope 
slide. We found that VWR superfrost slides, charged slides, poly-1-lysine coated slides, 
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and silane coated slides would not sufficiently attach cryo-protected, frozen, fixed tissue 
that were cut at 30, 50, or 100 um thicknesses. Even paraffin embedded sections detach at 
high incubation temperatures during the initial steps of in situ hybridization. Fortunately, 
the tissue remains adhered to microscope slides long enough to stain them with cresyl 
violet and allowed us to generate a small atlas of 45 sagittal sections from the developing 
chick heart (72-80 hours). Despite our lab having a rather extensive collection of chick 
developmental texts and papers, it is extremely difficult to assign a specific developmental 
stage to any whole mount unstained embryo, as evidenced by the numerous and obvious 
anatomical discrepancies present throughout these developmental textbooks and the 
literature at large. Even upon staining, various texts and papers ascribe a different 
developmental stage to embryos that appear identical, and the same developmental stage to 
embryos that exhibit subtle but definable and important anatomical differences. 
Construction of a developmental atlas for the chick using both whole mount and sectioned 
embryos at a variety of planes for each "HH" stage will provide useful data for 
developmental biologists. 
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APPENDIX A 
In Situ Hybridization Protocol 
Day 1: Fixation and Dehydration 
1. Fix embryos in 4% PFA in PBS for 4 hours in 4°C in liquid scintillation vials with 
tightly fitting screw caps. 
2. Dehydrate embryos in methanol gradient: 10%, 30%, 50%, 70%, 90%, and 100% 
for 10 minutes each at RT on shaker. A maximum of 10 embryos per vial and 10 
mL of methanol gradient per vial can be used. Methanol gradient is made with 
ddH20. Solutions can gently be decanted from one gradient to the next such that 
embryos are not lost or damaged during this process. Embryos can be stored in 
100% methanol in 4°C, or you can proceed to the next step. It is best to leave the 
embryos in fresh 100% MeOH if you will be storing them. 
Day 2: Rehydration and Hybridization 
1. Rehydrate embryos in methanol gradient: 90%, 70%, 50%, 30%, and 10% for 10 
minutes each at RT on shaker. Similar methodology as dehydration step. 
2. Wash in PBS-T in liquid scintillation vials for 15 minutes at RT on shaker. Use 
about 15 mL of PBS-T per vial. 
3. Gently transfer embryos to 48-well plate using a sterile spatula. Embryos will 
remain in plates throughout protocol and will be moved from well to well with a 
soft sable brush in each step. A maximum of 3 embryos per well should be used. 
Wash in 2X SSC for 10 min at RT on shaker. 
4. Statically incubate for 1 hour in pre-hybridization buffer at 68°C. 
5. Statically incubate in hybridization buffer (pre-hybridization buffer containing 
DIG-labeled RNA probe at 0.5 ug/mL concentration) at 68°C overnight. The user 
must use his/her discretion for the adequate amount of hybridization buffer per well 
such that all embryos are submerged in buffer, but excessive buffer is not wasted 
(as it is costly). Seal the plate with tape and adjust humidity of chamber by leaving 
a beaker of water in the hybridization oven. 
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Day 3: Washes, Labeling and Color 
As noted before, embryos are transferred from well to well with a soft sable brush in each 
step. On step 7, 8, and 9 a separate brush must be used as this brush will be in contact with 
the NBT/BCIP substrate solution and must not be used for other steps of this protocol. 
1. Wash 2x15 minutes at 37°C with 2 X SSC on shaker. 
2. Wash 2x15 minutes at 37°C with 1 X SSC on shaker. 
3. Wash 2 x 30 minutes at 37°C with 0.1 X SSC on shaker. These incubation times 
are a good chance to prepare the Block and Antibody Solution. Do not add the 
antibody until ready for step 5. 
4. Statically incubate in Blocking Solution19 for 1 hour at RT. (At this time, make 
fresh Buffer 2 & Color Solution.)16 
5. Incubate in Antibody Solution in humid shaking chamber for 2 hours at 37°C. 
6. Wash for 10 minutes at RT with Buffer # 1 on shaker. 
7. Wash for 10 minutes at RT with Buffer # 2 on shaker. 
8. Incubate tissue with NBT/BCIP substrate solution until you see signal. At this 
point, cover 48-well plate with aluminum foil and intermittently watch for signal 
development. Use a dissecting scope as needed. 
9. Stop color reaction with Buffer # 3. 
See Appendix B for how to make Block, Antibody Solution, Buffer 1, Buffer 2, Buffer 3, and Color 
Solution. 
51 
APPENDIX B 
Formulation of Buffers and Chemicals 
PBS-T 
1 X PBS and 0.1% Tween 20 
Pre-Hybridization buffer 
Formamide 
20X SSC 
50% Dextran Sulfate 
50X Denhardt's 
Salmon DNA 
Yeast tRNA 
Total Volume (mL) 
2.5 
1 
1 
0.1 
0.25 
0.125 
4.975 
3 
1.2 
1.2 
0.12 
0.3 
0.15 
5.97 
5 
2 
2 
0.2 
0.5 
0.25 
9.95 
7.5 
3 
3 
0.3 
0.75 
0.375 
14.925 
10 
4 
4 
0.4 
1 
0.513 
19.913 
12.5 
5 
5 
0.5 
1.25 
0.65 
24.9 
17.5 
7 
7 
0.7 
1.75 
0.9 
34.85 
Hybridization buffer 
0.5 ug/mL of DIG labeled RNA probe in pre-hybridization buffer. 
0.1X SSC, IX SSC, 2X SSC 
All made from manufactured 20X SSC and DEPC treated water. 
Block 
Scale to need: 
Buffer #1 3mL 
10% Triton X 30 ul 
Normal Sheep Serum 60 ul 
Antibody 
Scale to need: 
Buffer #1 2mL 
10% Triton X 20 ul 
Normal Sheep Serum 20 ul 
Anti-Dig Antibody 10 ul 
Buffer # 1: (lOOmM Tris-HCl; 150mM NaCl; pH 7.5) 
Tris-HCl 7.875 g 
NaCl 4.375 g 
DEPC H20 500 mL 
Filter the above mix. 
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Buffer # 2: (lOOmM Tris-HCl; lOOmM NaCl; 50mM MgCl2; pH 9.5) 
ALWAYS MAKE FRESH 
Tris-HCl 0.790 g 
NaCl 0.292 g 
MgCl2 0.508 g 
DEPC H20 50 mL 
Filter the above mix. 
Buffer # 3: (lOmM Tris-HCl; ImM EDTA; pH 8.0) 
Tris-HCl 0.79 g 
EDTA 0.184 g 
DEPCH20 500 mL 
Filter the above mix. 
Color Solution 
*Add the following to freshly made Buffer #2. 
NBT 22.5 ul 
BCIP 17.5 ul 
Levamisole 1.2 mg 
Buffer #2 5 mL 
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APPENDIX C 
Promega Wizard® Plus Midipreps DNA Purification System 
Instructions for Use of Products A7640, A7651 AND A7701, Protocol 
Preparation of Cleared Lysate 
1. Pellet cells at 10,000xg for 10 minutes at 4° C. 
2. Suspend pellet in 3 ml Cell Resuspension Solution. 
3. Add 3ml Cell Lysis Solution. Invert to mix.* 
4. Add 3ml of Neutralization Solution. Invert to mix. 
5. Centrifuge at 14,000 Xg for 15 minutes at 4°C. Decant supernatant containing 
DNA. 
Plasmid Purification 
6. Resuspend resin. Add 10ml resin to DNA from Step 5. Swirl to mix. 
7. Attach Midicolumn to vacuum manifold Transfer resin/DNA mixture to 
Midicolumn. Apply vacuum, releasing when all liquid has passed through the 
column.* 
Washing 
8. Add 15 ml Column Wash Solution containing ethanol. Apply vacuum, pulling 
liquid through column. Release vacuum. 
9. Repeat Step 8. After second wash, continue vacuum for 30 seconds after liquid has 
passed through the Midicolumn. Do not dry longer than 30 seconds. 
10. Separate Midicolumn and Reservoir. Place Midicolumn in 1.5 mL microcentrifuge 
tube. Centrifuge at 10,000 x g for 2 minutes. 
Elution 
11. Place Midicolumn in new 1.5 mL tube. Add 300 ul preheated water. Wait 1 
minute, then centrifuge at 10,000 x g for 20 seconds to elute DNA. Forpiasmids> iokb 
use water preheated to 70°C; for plasmids > 20 kb use water preheated to 80°C. 
12. Centrifuge eluate an additional 5 minutes at 10,000 x g to pellet resin fines. 
13. Transfer supernatant containing DNA to a new centrifuge tube. Store at -20°C or 
below. 
*For endA+ stains and other modifications, see additional protocol information in Technical Bulletin #TB173, 
available upon request from Promega or online at www.promega.com 
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APPENDIX D 
Alk2 Vector Map from Open Biosystems 
This image was reproduced with permission from Open Biosystems using 6418954 or 
BC058718 as search query. 
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APPENDIX E 
Probe Construction 
E.l. Probe Linearization and In Vitro Transcription 
Probe Linearization 
The following buffers and enzymes were obtained from Promega. 
Deionized water 
10 X buffer type 
10 X buffer Vol. 
BSA (acetylated) 
Plasmid DNA 
Enzyme (lOu/ul) 
Total 
In Vitro Transcription 
The following buffers and dNTPs were obtained from Ambion's Maxiscript. Digoxigenin-
labeled-UTP was purchased from Roche. 
Alk2 antisense 
319 ul 
H 
40.0 ul 
4.0 ul 
(0.75ug/ul) 27 ul 
(EcoRl)lOul 
400 ul 
Alk2 sense 
31.7 ul 
D 
4.0 ul 
0.4 ul 
(0.7ug/ul) 2.9 ul 
(Notl)l.Oul 
40.0 ul 
Nuclease-free water 
Linearized DNA template 
10 X Buffer for enzyme 
lOmMATP 
lOmMGTP 
10 mM CTP 
lOmMUTP 
Dig-labeled UTP 
Enzyme mix 
Total 
Alk2 antisense 
107.5 ul 
(0.8ug/ul) 12.5 ul 
20.0 ul 
10.0 ul 
10.0 ul 
10.0 ul 
6.0 ul 
4.0 ul 
(T3) 20.0 ul 
200.0 ul 
Alk2 sense 
(0.24 ug/ul) 
07) 
11.75ul 
6.25 ul 
3.0 ul 
1.5 ul 
1.5 ul 
1.5 ul 
0.9 ul 
0.6 ul 
3.0 ul 
30.0 ul 
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E.2. Precipitation of Linearized DNA 
1. Add equal volume of isopropanol. 
2. Chill at -20°C for at least 1 hour to overnight. 
3. Centrifuge at full speed for 15 minutes at 4°C. 
4. Aspirate the supernatant. 
5. Wash pellet with chilled 70% ethanol. 
6. Re-centrifuge for at full speed for 10 minutes at 4°C. 
7. Discard supernatant. 
8. Air-dry the pellet for 5 minutes. 
9. Re-suspend the DNA in the appropriate volume of TE buffer. 
10. Quantitate DNA by spectrophotometry. (Alk2 antisense =0.786ug/ul & sense 
=0.24ug/ul) 
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APPENDIX F 
Recipe for Phosphate Buffered Sucrose 
Phosphate buffered solutions of 10% and 30% sucrose were used for removing water from 
the embryo tissue so that once frozen; water crystals do not damage the tissue. 
Furthermore, this process helps cryo-protect the tissue as well. 
10% sucrose 
Sucrose 
Solution A 
Solution B 
NaCl 
KC1 
H20 
10 g 
20.25 mL 
4.75 mL 
0.8 g 
0.02 g 
tolOOmL 
30% sucrose 
Sucrose 
Solution A 
Solution B 
NaCl 
KC1 
H20 
30 g 
20.25 mL 
4.75 mL 
0.8 g 
0.02 g 
tolOOmL 
Solution A 
0.4 M solution: 
Sodium phosphate dibasic*7H20 107.228 g in 1L H20 
Solution B 
0.4 M solution: 
Sodium phosphate monobasic monohydrate 5 5 . 2 g i n l L o f H 2 0 
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APPENDIX G 
Paraffin embedding20 
After harvesting embryos, and fixation in 4 % PFA for 4 hours at room temperature, the 
following protocol was followed for paraffin embedding. 
1. Dehydrate embryos in methanol gradient: 25%, 50%, 75%, 85%, 95%, 100%, and 
100%o for 15 minutes each at RT on shaker. Embryos can be stored in 100%) 
methanol in 4°C, or you can proceed to the next step. 
2. Incubate tissue in 50% xylene/50% methanol on shaker at room temperature for 5 
minutes. 
3. Incubate tissue in 100% xylene on shaker at room temperature for 10 minutes. 
4. Incubate tissue in 100% xylene for 5 minutes. 
5. Incubate tissue in 50% paraffin/50%) xylene at 60°C for 1.5 hours. 
6. Incubate tissue in 75% paraffin/25% xylene at 60°C for 30 minutes. 
7. Incubate tissue in 100% paraffin at 60°C for 1 hour. 
8. Incubate in 100%> paraffin at 60°C for 4 hours. 
9. Incubate in 100%> paraffin at 60°C overnight. 
10. Next morning, replace paraffin and let incubate at 60°C for 10 minutes. 
11. Add to molding trays and let solidification to occur. 
The protocol for paraffin embedding has been optimized and improved by Ricardo Leitao until this 
protocol was established. Please refer to his graduate research thesis for more information on this topic. 
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APPENDIX H 
QIAGEN MiniElute Gel Extraction Kit Protocol 
1. Carefully excise bands. 
2. Weigh slices. (Cannot use more than 400mg) 
3. Add 3 vol. of buffer QG for 2% gels. (i.e. 300ul to 1 OOmg or 6 vol. for higher % 
gels) 
4. Incubate at 50°C for 10 minutes. (Until gel dissolves completely. The color of the 
solution should be yellow at this point.) 
5. Add 1 gel volume isopropanol (i.e. 100 ul to 100 mg) and mix by inverting. 
6. Apply sample to column. Centrifuge at max speed for 1 minute. Discard flow-
through. 
7. Add 500 ul of buffer QG. Centrifuge at max speed for 1 minute. Discard flow-
through. 
8. Add 750 ul of buffer PE. 
9. Let stand for 5 minutes. 
10. Centrifuge at max speed for 1 minute. Discard flow-through. 
11. Centrifuge again at max speed for 1 minute. 
12. Place column in new 1.5 mL tube. 
13. Elute DNA by adding 10 ul of buffer EB. 
14. Let stand for 1 minute. 
15. Centrifuge at maximum speed for 1 minute. 
16. Quantitate DNA by spectrophotometry. 
The band excised was about 50 mg in weight. This resulted in using 150 ul of buffer QG 
for step 3 and 50 ul of isopropanol in step 5. Finally, for step 13, 15 ul of buffer EB was 
added to the column resulting in a DNA concentration of 16.4 ng/ul. 
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APPENDIX I 
RT-PCR Reaction and Program 
The following RT-PCR reaction mix was assembled on ice using QIAGEN's one-step RT-
PCR kit. 
RNase-free Water 
5X Qiagen OneStep RT-PCR Buffer 
dNTP Mix (containing 10 uM of each dNTP) 
5X Q Solution 
Alk2 forward (10 uM) 
Alk2 reverse (10 uM) 
QIAGEN OneStep RT-PCR Enzyme mix 
RNA(1.4ug/ul) 
Total 
Vz Volume/Rxn 
11.5 ul 
5ul 
lul 
5ul 
0.5 ul 
0.5 ul 
lul 
0.5 ul 
25 ul 
After reaction was prepared, the following step-down one-step RT-PCR program was used. 
Annealing temperature was based on average Tms of primers which was an average of 
56°C. A step-down annealing reaction will increase specificity during initial cycling as 
higher temperatures will limit nonspecificty. 
Reverse Transcription 
Initial PCR activation step 
3-step cycle: 
Denaturation 
Annealing 
Extenstion 
Each cycle, the annealing temperature drops 0.5°C 30 cycles 
(ranging from 66°C to 51°C) 
50°C 
95°C 
94°C 
66°Cto51°C 
72°C 
30 minutes 
5 minutes 
45 seconds 
45 seconds 
1.5 minutes 
Annealing temperature at 51 °C 
Final extension 72°C 
10 cycles 
10 minutes 
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APPENDIX J 
Raw Data from Sequetech Corporation 
The insert was sequenced from both directions resulting in a forward and reverse strand 
(Sequetech, DNA Sequencing). In order to compare the two strands, a reverse complement 
was made from the reverse strand. Subsequently, M13_For was compared to the reverse 
complement. The green areas are plasmid DNA and the red regions are the overlapping 
regions between the forward and reverse. Since the insert was about 1300 base pairs, the 
forward and reverse bands were only able to provide half of the equation. Therefore, these 
two pieces were combined together to give the final sequence shown in the results section. 
>#10;M13_For 
CCGTGCKjCATATCiATTlTATTTTC)AC'TCiATACiTGAttTGTTC'nTlXK:AAC'AAATTGATCiACit"AAlXjC'TTTTTI"ATAATCiC'C 
AACTTTGTACAAAAAAGCAG(iCTCCXiAATTCGt'C(."TTGTCATGTGGGAATGGAGACCGCTGCCAGGGCCAGCAGTGCTTC 
GCCTCCCTGAGCATTAACGATGGTGCTAAGGTTTACCAGAAAGGCTGCTTCCAAGTCTATGAACAAGGGAAAATGACGTG 
CAAAACTCCGCCATCTCCTGACCAAGCTGTGGAGTGCTGCCAAGGATACCTTTGCAACATGAATATCACTGCGAAGTTGC 
CCTCTTCTAAAGGGCAAACCCTGCAAGGGGAAGCTGCAGGTTACAGCATGGAAACACTAATCATCGTTATACTGGCTCCT 
GTAGTAGTGCTGGTAATTTTCTCTGTGGTAGCTGTGCTCATCATCCGGAGGATACAGAAGAACCACATGGAGAGACTCAA 
TTCTAGAGATGCAGAATATGGCACAATTGAGGGACTCATTGCTTCAAATGTTGGAGACAGTACATTGGCAGATTTATTGG 
ACCATTCCTGCACATCTGGAAGTGGTTCTGGACTTCCATTCTTGGTGCAAAGAACAGTGGCTCGCCAGATCACGCTTGTGG 
AGTGTGTAGGAAAGGGCCGTTATGGAGAAGTCTGGAGGGGTCAGTGGCAAGGAGAGAATGTTGCTGTGAAGATCTTCTC 
TTCTAGGGATGAAAAATCCTGGTTCAGGGAAACTGAATTGTATAACACTGTGTTGCTGCGGCATGAAAACATTTTAGGTTT 
TATTGCATCCGATATGACTTCCAGAAACTCTAGCACCCAGCTGTGGCTAATTACTCACTACCATGAGATGGGGTCTTTGTA 
TGACTATCTGCAGCTCACACCCTGGACACTGTCAGCTGCCTGCGGATAGTACTGTCATAGCAGCGGCCTGCACATTT 
GCACATAGAGATATTTGGACGCAGGGAAGCTTCCATTCTC 
>#10;M13_Rev 
TGTTCGACTATATAGGGGAATCAGCTGGATGGCAAATAATGATTTTATTTTGACTGATAGTGACCTGTTCGTTGCAACAAA 
TTGATGAGCAATTATTTTTTATAATGCCAACTTTGTACAAGAAAGCTGGGTCGAATTCGCCCTTTTCGCAGGGCTGTTAGT 
CTTGCTGATGGATTCTGATACCAGCATTCTTTCATCAACTTGGCAAGAGATGTTAATGTAGGGTCTGAGAACCACCTGTTG 
GGAATGTTTGGCCTTTGCTGATCTACACAGACCACTTTCCTCATGTCTTCAAAACTGGGATCATTTGGAACCAGGTCATAA 
AATGGTGGTTTATAGTCTTCTACAATACCATTGCTAACCATGCGCCTAGCTACCTCCCACAGGACCAGCCCGAAGGCCCA 
GATATCGACCCTCTTGTAGGAGTCGAAGCAGTCTGCCTGGATGGTTTCGTCCAAGACCTCCGGAGCCATGTAGCGTTTGGT 
GCCCACTCGGGGGTTGTTCCCCACATCCAACTGGTTCGTGCTTTGGGAGTGCATGACTGCGAGGCCTAAGTCTGCTATGCA 
GCACTGTCCATTTTTCTTAACAAGGATATTTTTGCTCTTCAAGTCCCGATGAGAAATGGCAGGCTTCCCCTGCGTTCCAAA 
TATCTCTATGTGCAAATGTGCAAGGCCGCTGGCTATGGACAGTACTATCCGCAGGCAGCTGACAGTGTCCAGGGTGGTGA 
GCTGCAGATAGTCATACAAAGACCCCATCTCATGGTAGTGAGTAATTAGCCACAGCTGGGTGCTAGAGTTTCTGGAAGTC 
ATATCGGATGCAATAAAACCTAAAATGTTTTCATGCCGCAGCAACACAGTGTTATACAATTCAGTTTCCCTGAACCAGGA 
TTTTCATCCCTAGAAGAGAAGATCTTCACAGCACATTCTCTCTTGCCACTGACCCCCCAGACTCTCCATAACG 
GCCTTTCTAACCCTCCACAAGCGTGATCTGGCGAGCACTG 
>REVERSE COMPLEMENT of M13_Rev 
CAGTGCTCGCCAGATCACGCTTGTGGAGGGTTAGAAAGGCCGTTATGGAGAGTCTGGGGGGTCAGTGGCAAGAGAGAAT 
GTGCTGTGAAGATCTTCTCTTCTAGGGATGAAAATCCTGGTTCAGGGAAACTGAATTGTATAACACTGTGTTGCTGCGGCA 
TGAAAACATTTTAGGTTTTATTGCATCCGATATGACTTCCAGAAACTCTAGCACCCAGCTGTGGCTAATTACTCACTACCA 
TGAGATGGGGTCTTTGTATGACTATCTGCAGCTCACCACCCTGGACACTGTCAGCTGCCTGCGGATAGTACTGTCCATAGC 
CAGCGGCCTTGCACATTTGCACATAGAGATATTTGGAACGCAGGGGAAGCCTGCCATTTCTCATCGGGACTTGAAGAGCA 
AAAATATCCTTGTTAAGAAAAATGGACAGTGCTGCATAGCAGACTTAGGCCTCGCAGTCATGCACTCCCAAAGCACGAAC 
CAGTTGGATGTGGGGAACAACCCCCGAGTGGGCACCAAACGCTACATGGCTCCGGAGGTCTTGGACGAAACCATCCAGG 
CAGACTGCTTCGACTCCTACAAGAGGGTCGATATCTGGGCCTTCGGGCTGGTCCTGTGGGAGGTAGCTAGGCGCATGGTT 
AGCAATGGTATTGTAGAAGACTATAAACCACCATTTTATGACCTGGTTCCAAATGATCCCAGTTTTGAAGACATGAGGAA 
AGTGGTCTGTGTAGATCAGCAAAGGCCAAACATTCCCAACAGGTGGTTCTCAGACCCTACATTAACATCTCTTGCCAAGTT 
GATGAAAGAATGCTGGTATCAGAATCCATCAGCAAGACTAACAGCCCTGCGAAAAGGGC CiAATTCXiACC( AGCTTTCTTG 
I'AC'AAAGTTGGCATTATAAAAAAl'AATTCiCTC ATCAATTTGTTGCAACGAACAGGTt'AC'TATCACiTC 'AAAATAAAATC'AT 
TATTTGC C ATCC AC "iCTG ATTCX.'(X TATATAGTCGAACA 
